Classic and new candidate markers for drug resistance in a large cohort of leprosy patients from the Amazon state, Brazil
Antimicrobial Agents and Chemotherapy · 2025
DOI: 10.1128/aac.01550-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Cynthia de Oliveira Ferrreira und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Biologia Molecular, Fundação Hospitalar Alfredo da Matta-FUHAM, Manaus, Amazonas, Brazil. Hauptthemen laut MEDLINE: Leprosy, Mycobacterium leprae, Leprostatic Agents, Drug Resistance, Bacterial. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Multidrug therapy for leprosy is highly effective and the recommended standard of care for leprosy worldwide. However, reports of antimicrobial resistance (AMR) have emerged globally. This study aimed to estimate the frequency of primary and secondary AMR associated with leprosy in patients treated at the Alfredo da Matta Foundation, Manaus, Amazonas, Brazil, as well as to determine the circulating subtypes of Mycobacterium leprae in this population. A total of 315 biopsy samples were investigated for variants in leprosy AMR-associated genes ( rpoB, folP1, gyrA ); a subset of 163 samples was also investigated for 5 additional candidate genes: gyrB, ctpC, ctpI, ribD , and fadD9 . Patients were categorized into new cases, relapses, and suspected treatment failures. For statistical analysis, Pearson’s chi-square or Fisher’s exact test was employed for categorical variables, while mean and SD were calculated for continuous variables, with a significance level of 5%. Variant analysis detected 10 resistant M. leprae isolates displaying mutations in the rpoB (2, 0.6%) and folP1 (8, 2.5%) genes. In addition, variants in gyrB (1, 0.6%), ctpC (6, 3.7%), ribD (4, 2.4%), and fadD9 (15, 9.2%) were detected. Nine out of 10 resistant isolates were observed in the relapse group ( P = 0,0014). Despite the low variant frequencies observed, variant detection highlights the need for expanded antimicrobial monitoring and surveillance. The impact of mutations in ribD and fadD9 on therapeutic response remains unclear, underscoring the need for further research. Genotyping revealed subtype-4 predominance (79.6%). Our findings highlight the importance of comprehensive AMR monitoring, particularly in relapse cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratório de Biologia Molecular, Fundação Hospitalar Alfredo da Matta-FUHAM, Manaus, Amazonas, Brazil.
- Genomic Health Surveillance Network: Optimization of Assistance and Research in the State of Amazon (REGESAM), Manaus, Amazonas, Brazil.
- Programa de Pós-Graduação em Medicina Tropical, Universidade do Estado do Amazonas-UEA, Manaus, Amazonas, Brazil.
- Instituto de Pesquisa Clínica Carlos Borborema, Fundação de Medicina Tropical Dr Heitor Vieira, Manaus, Amazonas, Brazil.
- Laboratório de Biologia Molecular, Instituto Lauro de Souza Lima, Bauru, Brazil.
- Graduate Program in Health Sciences, School of Medicine and Life Sciences, Pontifícia Universidade Católica do Paraná, Curitiba, Brazil.
ORCID-Profile: Cynthia de Oliveira Ferrreira, Gisely Cardoso Melo
Zitieren
APA
Ferrreira, C. O., Leturiondo, A. L., Dos Santos, C. G., da Silva, J. B., Souza, M. F. A., Rego, C. B. O., de Souza, G. C., Pinheiro, T. B., Melo, G. C., Rosa, P. S., Mira, M. T., Avanzi, C., & Talhari, C. (2025). Classic and new candidate markers for drug resistance in a large cohort of leprosy patients from the Amazon state, Brazil. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01550-24
Vancouver
Ferrreira CO, Leturiondo AL, Dos Santos CG, da Silva JB, Souza MFA, Rego CBO, et al. Classic and new candidate markers for drug resistance in a large cohort of leprosy patients from the Amazon state, Brazil. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.01550-24
BibTeX
@article{Ferrreira2025,
author = {Ferrreira, Cynthia de Oliveira and Leturiondo, André Luiz and Dos Santos, Camila Gurgel and da Silva, Jaqueline Bentes and Souza, Michelle Fernanda de Andrade and Rego, Catherine Bianca Oliveira and de Souza, Guilherme Caldas and Pinheiro, Thamires Bastos and Melo, Gisely Cardoso and Rosa, Patricia Sammarco and Mira, Marcelo Távora and Avanzi, Charlotte and Talhari, Carolina},
title = {Classic and new candidate markers for drug resistance in a large cohort of leprosy patients from the Amazon state, Brazil},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2025},
doi = {10.1128/aac.01550-24}
}
EUVIMED